HEATHER MOTT: Open Payments
NPI 1568707370 · JEFFERSONVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 11 payments from 8 companies in 2025. Trend: 2023 $497 · 2024 $484 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, REXULTI, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, Dyanavel XR, INGREZZA.
Industry payments across IN — which companies pay providers there.
